Shionogi
Alan Bianchi is an accomplished leader in pharmaceutical marketing and commercialization, currently serving as the Sr. Director, Launch Lead for Ensitrelvir at Shionogi Inc. since December 2023. Bianchi has extensive experience in strategic planning and market execution, having previously held roles as Commercial Lead Advisor at ASLAN Pharmaceuticals and Executive Director and US Marketing Lead for ADBRY at LEO Pharma. Notable achievements include successful product launches, brand strategy development, and significant market impact within multiple therapeutic areas, particularly in dermatology and immunology. With a foundation built on roles at Sanofi Genzyme, Forest Laboratories, and Bayer Consumer Healthcare, Bianchi has demonstrated expertise in leading cross-functional teams and driving commercial success. Bianchi holds an MBA in Marketing and Operations Management and a Bachelor of Science in Chemical Engineering from the University of Rochester.
This person is not in any teams
This person is not in any offices
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.